The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years.

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt ...

The top line of UnitedHealthcare, the company's insurance and managed care business, rose 6.1% to $74.1 billion. Analysts had been looking for $75.22 billion. Revenue from Optum, its ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If you were enrolled in Medicare Part B before 2025, your premium may increase. For new enrollees in 2025, the standard monthly premium is set at $185. However, individuals earning more than $ ...

The integration of Fusion with FactSet was prompted by J.P. Morgan's institutional clients, who wanted to receive J.P. Morgan data using modern technology, according to Jason Mirsky, J.P. Morgan ...

The integration of Fusion with FactSet was prompted by J.P. Morgan's institutional clients, who wanted to receive J.P. Morgan data using modern technology, according to Jason Mirsky, J.P. Morgan ...

Medicare premiums and deductibles increased in 2025 from 2024 levels, with Part B premiums rising by about 6%. To get the most from your plan, it’s important to understand your out-of-pocket ...

The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...

FactSet Research Systems FDS stock has had an impressive run over the past six months. Shares have risen 9.4% compared with the industry’s 5.6% growth and the Zacks S&P 500 composite’s 6.3% ...